231 related articles for article (PubMed ID: 24388569)
1. Peroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production.
Misztal T; Rusak T; Tomasiak M
Thromb Res; 2014 Mar; 133(3):402-11. PubMed ID: 24388569
[TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite--altered platelet mitochondria--a new link between inflammation and hemostasis.
Misztal T; Przesław K; Rusak T; Tomasiak M
Thromb Res; 2013 Jan; 131(1):e17-25. PubMed ID: 23200902
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria.
Misztal T; Rusak T; Tomasiak M
Free Radic Res; 2014 Dec; 48(12):1443-53. PubMed ID: 25236568
[TBL] [Abstract][Full Text] [Related]
4. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite can affect platelet responses by inhibiting energy production.
Rusak T; Tomasiak M; Ciborowski M
Acta Biochim Pol; 2006; 53(4):769-76. PubMed ID: 17068635
[TBL] [Abstract][Full Text] [Related]
6. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
[TBL] [Abstract][Full Text] [Related]
7. Reduced clot retraction rate and altered platelet energy production in patients with asthma.
Tomasiak-Lozowska MM; Rusak T; Misztal T; Bodzenta-Lukaszyk A; Tomasiak M
J Asthma; 2016 Aug; 53(6):589-98. PubMed ID: 27145190
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
9. Quantification and optimization of clot retraction in washed human platelets by Sonoclot coagulation analysis.
Yadav P; Beura SK; Panigrahi AR; Singh SK
Int J Lab Hematol; 2022 Feb; 44(1):177-185. PubMed ID: 34609044
[TBL] [Abstract][Full Text] [Related]
10. Serine/threonine phosphatases regulate platelet αIIbβ3 integrin receptor outside-in signaling mechanisms and clot retraction.
Moscardó A; Santos MT; Latorre A; Madrid I; Vallés J
Life Sci; 2013 Nov; 93(20):707-13. PubMed ID: 24096143
[TBL] [Abstract][Full Text] [Related]
11. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets.
Reid TJ; Snider R; Hartman K; Greilich PE; Carr ME; Alving BM
Vox Sang; 1998; 75(4):270-7. PubMed ID: 9873262
[TBL] [Abstract][Full Text] [Related]
12. Studies on pig blood platelet responses to peroxynitrite action.
Nowak P; Wachowicz B
Platelets; 2001 Sep; 12(6):376-81. PubMed ID: 11672476
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.
Tutwiler V; Litvinov RI; Lozhkin AP; Peshkova AD; Lebedeva T; Ataullakhanov FI; Spiller KL; Cines DB; Weisel JW
Blood; 2016 Jan; 127(1):149-59. PubMed ID: 26603837
[TBL] [Abstract][Full Text] [Related]
14. The fate of mitochondria during platelet activation.
Grichine A; Jacob S; Eckly A; Villaret J; Joubert C; Appaix F; Pezet M; Ribba AS; Denarier E; Mazzega J; Rinckel JY; Lafanechère L; Elena-Herrmann B; Rowley JW; Sadoul K
Blood Adv; 2023 Oct; 7(20):6290-6302. PubMed ID: 37624769
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
Tanoue K; Katagiri Y; Suzuki H
Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
[TBL] [Abstract][Full Text] [Related]
16. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
[TBL] [Abstract][Full Text] [Related]
18. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development.
Carr ME; Carr SL
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):79-86. PubMed ID: 7795157
[TBL] [Abstract][Full Text] [Related]
19. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
20. Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis.
Corbalan JJ; Medina C; Jacoby A; Malinski T; Radomski MW
Int J Nanomedicine; 2012; 7():631-9. PubMed ID: 22334785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
